bivalirudin (Kereos)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebivalirudin (Kereos)
Drug Alias NameBVR-NP
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKereos Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A